Xenetic Biosciences, Inc. current report, 16 April 2012

SEC Filing Summary: General Aircraft, Inc. (Form 8-K)

Business Context and Reporting Period

This Form 8-K was filed by General Aircraft, Inc. on April 16, 2012, reporting events occurring on the same date. The registrant is incorporated in Nevada and is headquartered in Las Vegas, NV. The filing details the completion of an initial public offering (Offering) pursuant to a Registration Statement on Form S-1/A that became effective on March 22, 2012.

Key Financial Metrics

The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, or debt levels. The only specific financial data disclosed relates to the capital raise:

  • Total Capital Raised: $35,000
  • Shares Issued: 3,500,000 shares of common stock
  • Offering Price: $0.01 per share
  • Number of Subscribers: 30

Material Changes

The primary material change reported is the issuance of 3,500,000 shares to 30 subscribers, resulting in the company raising $35,000. This transaction was executed by the company's sole officer and director, Ian Johnson.

Outlook, Risks, and Management Commentary

Management has committed to updating the Prospectus as required by law and continuing to file all required reports with the Securities and Exchange Commission. The filing does not contain specific forward-looking guidance, risk factors, or discussion of contingencies beyond the standard regulatory compliance statement.

Investor Verification Checklist

  • Verify the effectiveness of the Form S-1/A Registration Statement dated March 22, 2012.
  • Confirm the current share count and capitalization structure following the issuance of 3,500,000 shares.
  • Review the updated Prospectus for any material changes to the business plan or use of proceeds.
  • Investigate the operational status of General Aircraft, Inc., given the minimal capital raised ($35,000) and the single officer/director structure.